Precision System Science Co Osake

Precision System Science Co EV/FCF

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Precision System Science Co (7707.T) 24.7.2026 päivämäärällä on 131,36. Edellisenä vuonna EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) oli −42,38 — muutos −409,98 % (korkeampi).

EV/FCF

131,36

YoY

−409,98%

Viimeksi päivitetty:

EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Precision System Science Co on 2026 131,36 . EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) yhtiöstä Precision System Science Co oli 2025 −42,38 . Se laskee −409,98% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Precision System Science Co Osakeanalyysi

Mitä Precision System Science Co tekee? Precision System Science Co Ltd is a leading company in the field of medical research and diagnostics, founded in Japan in 1989. The company is headquartered in Chiba, Japan and operates branches in Europe, the USA, and Asia. Its business model is focused on providing a wide range of instruments, devices, and services for research, diagnostics, and therapy in the medical industry. The company designs and produces its own products and also offers customized solutions for customers. It is divided into different divisions, including instruments and devices for molecular biology and diagnostics, cell analysis, microscopy, and sample processing. They offer products such as PCR systems, qPCR systems, automated sample preparation systems, and RNA isolation kits for molecular biology and diagnostics. They also produce cell counting systems, flow cytometers, high-speed imaging systems, multi-well plate readers for cell analysis. In the microscopy division, the company manufactures high-quality fluorescence microscopes and deconvolution microscopes for protein and DNA molecule analysis, disease diagnostics, drug development, etc. In the sample processing division, they produce automated stations used for preparing samples for genomics and proteomics analysis. The company is also engaged in research and development of medical devices and instruments to improve the quality of medical diagnostics and therapy. A successful product example is the qPCR thermocycler MIQE used in the diagnosis and therapy of diseases like cancer. Precision System Science Co Ltd has played a significant role in fighting the COVID-19 pandemic by producing test kits for diagnosis and offering advanced PCR systems for mass testing. They are committed to continuous innovation and improvement of their products and services to meet the changing needs of the medical industry. With their strong presence and dedication to providing state-of-the-art and innovative products and services, they will remain a major player in the global market for medical devices and instruments. Precision System Science Co on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Precision System Science Co osakkeesta

Yhtiön Precision System Science Co EV/FCF (Yrityksen arvo suhteessa vapaaseen kassavirtaan) on 131,36 vuonna 2026.

Access this data via the Eulerpool API

Arvostus — Precision System Science Co

Kaikki tunnusluvut — Precision System Science Co